HuagongsheHuagongshe Chemistry Print Report · For research reference only
Diethyl Ether → Erlotinib Hydrochloride
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Diethyl Ether | HCID 3283 | — |
| Reactant | Erlotinib | HCID 176870 | — |
| Reactant | Ether hydrochloride | HCID 10953452 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | Erlotinib Hydrochloride | HCID 176871 | — |
Reaction Steps
Erlotinib free base (5 gm, obtained in reference example 3) is dissolved in chloroform (200 ml) at 25-30° C. to form a clear solution and then added diethyl ether (50 ml). To the resulting solution slowly added 15% diethyl ether HCl (5 ml) at 25-30° C. and stirred for 30 minutes at 25-30° C. Filtered the material, washed with a mixture of diethyl ether (10 ml) and chloroform (10 ml), and then dried at 60-65° C. under vacuum to give 4.9 gm of erlotinib hydrochloride polymorph form A [HPLC purity: 99.7%; Mean particle size (D50): 3.50 μm and 90 volume-% of the particles (D90): 4.61 μm].
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08669265B2 |
| Source dataset | uspto-grants-2014_03 |
| ORD ID | ord-643d4aafd25d4d22b5cf876f527ab72c |
| Source note | uspto-grants-2014_03 |